Monza, Italy

Ermanno Valoti

This inventor holds 1 USPTO granted patent. Top assignee: Chementecno S.r.l.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ermanno Valoti. Retrieved from https://idiyas.com/inventor/ermanno-valoti-m3pias98

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ermanno Valoti

Introduction

Ermanno Valoti is a notable inventor based in Monza, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative processes. His work focuses on the preparation of pharmaceutically acceptable salts, which are crucial for drug formulation.

Latest Patents

Valoti holds a patent for a process for the preparation of pharmaceutically acceptable salts of (R,S)-S-adenosyl-L-methionine. This invention allows for the production of the salified (R)-(+)-S-adenosyl-L-methionine diastereoisomer in amounts lower than or equal to 3% compared to the salified (S)-(+)-S-adenosyl-L-methionine diastereoisomer. The salts produced by this process maintain their configuration stability over time, which is essential for pharmaceutical applications.

Career Highlights

Valoti is associated with Chementecno S.r.l., where he applies his expertise in pharmaceutical chemistry. His innovative approach has positioned him as a valuable asset in the industry, contributing to advancements in drug formulation and development.

Collaborations

He has collaborated with notable colleagues such as Marco Berna and Lino Sivieri, enhancing the research and development efforts within his company.

Conclusion

Ermanno Valoti's contributions to pharmaceutical innovation through his patented processes demonstrate his commitment to advancing the field. His work not only enhances drug formulation but also ensures the stability and efficacy of pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…